Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥16.44 - CN¥26.36
Next Earnings Date
May 16 2025 (Estimate)
Next Earnings Date
May 16 2025 (Est.)
Latest price
Market Cap | CN¥10.92B |
EV | CN¥6.90B |
Shares Outstanding | 569.72M |
Beta | 0.68 |
Analyst Rating | BUY |
Analyst Target Price | CN¥24.45 |
P/E 2025E | 24.88x |
P/Revenue 2025E | 5.42x |
Revenue | -30.80% |
EPS | -51.10% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 79.43% |
Net Profit Margin 2025E | 20.83% |
ROE 2025E | 5.30% |
ROCE 2024 | 3.59% |
DPS 2025E | CN¥0.52 |
Payout Ratio 2025E | 67.53% |
Div. Yield 2025E | 2.71% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Sansure Biotech Inc.
688289
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Dai, Lizhong
Employees
2,006
Website
www.sansure.com.cnIPO Date
2020-08-28
Headquarters
No. 680, Lusong Road, High-tech Industrial Development Zone, Changsha, Hunan Province, 410205, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved